A phase I trial of enzastaurin in patients with recurrent gliomas. - Wikidata - awgldk - TriplyDB

A phase I trial of enzastaurin in patients with recurrent gliomas.

A phase I trial of enzastaurin in patients with recurrent gliomas.

http://www.wikidata.org/entity/Q33384375

about

Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma Glycogen Synthase Kinase-3 (GSK-3)-Targeted Therapy and Imaging Novel delivery strategies for glioblastoma The role of imaging in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.A phase 1 and pharmacokinetic study of enzastaurin in pediatric patients with refractory primary central nervous system tumors: a pediatric brain tumor consortium study.Experimental approaches for the treatment of malignant gliomas.Small molecule kinase inhibitors in glioblastoma: a systematic review of clinical studies.Pathway inhibition: emerging molecular targets for treating glioblastoma.Phase 1 trial of dichloroacetate (DCA) in adults with recurrent malignant brain tumors.Phase I study of enzastaurin and bevacizumab in patients with advanced cancer: safety, efficacy and pharmacokinetics.A pharmacokinetic and safety study of a fixed oral dose of enzastaurin HCl in native Chinese patients with refractory solid tumors and lymphoma.Standards of care and novel approaches in the management of glioblastoma multiforme.AKT/GSK3β Signaling in Glioblastoma.Antiangiogenic therapy and mechanisms of tumor resistance in malignant glioma.Anti-angiogenic therapy in glioma.Understanding Disease-Drug Interactions in Cancer Patients: Implications for Dosing Within the Therapeutic Window.Clipping the Wings of Glioblastoma: Modulation of WNT as a Novel Therapeutic Strategy.Targeted Cancer Therapies and QT Interval Prolongation: Unveiling the Mechanisms Underlying Arrhythmic Complications and the Need for Risk Stratification Strategies.Multicenter phase II trial of enzastaurin in patients with relapsed or refractory advanced cutaneous T-cell lymphoma.Targeting PKC-mediated signal transduction pathways using enzastaurin to promote apoptosis in acute myeloid leukemia-derived cell lines and blast cells A phase 1/2 study of orally administered synthetic hypericin for treatment of recurrent malignant gliomas.

P2860

Q24632791-3E3DA98B-1548-4F1B-9DFE-2567877130DB Q26768475-AB387321-861A-4788-A09E-D3FA02A36DBF Q27006099-6ABA63EB-A71F-47C5-BB3F-C86E637A0E52 Q30797166-018F93AD-27BC-4EB3-8D29-F3EEE1506A8E Q33418912-387112C4-BF42-464D-AE25-A64DDD530517 Q34127138-C3E71A4B-7351-438E-90BA-7BA1785F918B Q34132781-9DBF5B77-4DED-4F0C-B4E8-1CA95135B9ED Q35021359-BF14E157-3205-4F34-A4A4-E34BDBB28659 Q35684292-31B7F95F-7B06-4ED0-9B95-5F18727F514E Q36816535-2FAF458F-0EB0-4EEE-B4D5-88506769CDD4 Q37109823-6205BF69-1400-46B9-A17D-885338BD5452 Q37525881-95AB857B-DA8B-4D5C-9D97-6322D253F74C Q37710163-27BCF004-9183-4C4A-B84C-28CF92E10029 Q37736273-C9C6B5D6-0EBE-4EE4-B0DE-1D2EC4B3DEDB Q37877409-960CDF49-87F2-4313-97F9-AF33DBAB22BD Q38390695-0FF0E85E-4779-47CA-A75E-148CBF864ACB Q38775522-FDE0A4F1-F9FB-46FF-AB4D-B427FD48300C Q38956949-EEB3E989-59B1-427C-B8F3-14D5CA773ED9 Q39264679-D8F9C9BE-73F1-426B-A64D-4BB46348EB9D Q39584277-B71F5ED6-5ABF-467D-B952-8320176A06F3 Q55463279-2CFC3624-B0EF-4941-91AE-105DA87F45AD

P2860

A phase I trial of enzastaurin in patients with recurrent gliomas.

http://www.wikidata.org/entity/Q33384375

description

2009 nî lūn-bûn

@nan

2009 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

A phase I trial of enzastaurin in patients with recurrent gliomas.

@ast

A phase I trial of enzastaurin in patients with recurrent gliomas.

@en

type

label

A phase I trial of enzastaurin in patients with recurrent gliomas.

@ast

A phase I trial of enzastaurin in patients with recurrent gliomas.

@en

prefLabel

A phase I trial of enzastaurin in patients with recurrent gliomas.

@ast

A phase I trial of enzastaurin in patients with recurrent gliomas.

@en

P1433

Q33384375-CC663E0D-AC99-4FD9-B006-BA5E9AB67DE7

P1476

Q33384375-9C165C81-D3CE-4010-B021-7AF67E255E08

P2093

Q33384375-17439C97-2168-4AC8-973B-94434BA68B78

Q33384375-19E1BEAE-EFF9-49D7-A772-3090077F66EA

Q33384375-3F1B4D98-57A5-47A0-BFB4-68CDCEBEA8BF

Q33384375-7AB6AB7E-8C8F-467A-B881-F4AF29D97F45

Q33384375-7ACFC334-B762-425E-9F81-3801DA09AF56

Q33384375-9ACDEDC5-996E-483D-9D21-124B6241C917

Q33384375-BC3AC94B-10A4-49E6-B56F-49FAF918D009

Q33384375-DF189C0D-B292-4E8F-99A4-D3D345BDE55C

Q33384375-F72ACB0B-0361-47F6-BA83-C5826782BF2D

Q33384375-FBF57868-31A6-48CC-B5A1-CD65B9460664

P304

Q33384375-AFB5173F-855A-446B-86D1-4BBB0054F631

P31

Q33384375-41E5EA5C-086B-4867-AE4D-88677242BCC9

P356

Q33384375-8E1F3185-D8D7-4324-9402-5C3008C4CEC9

P407

Q33384375-2995E8BC-2FF5-4E68-B86C-9AAC01AC1C42

P433

Q33384375-8C86FF3E-7C1B-487F-9177-5A6F8E02577D

P478

Q33384375-C193DCB9-EF22-4519-9B51-D0DE2CBAB3F8

P577

Q33384375-54BC83D9-7C36-4F67-AF16-05E8502B57E2

P698

Q33384375-4898FB1C-705E-4B7A-A533-A06239B52685

P921

Q33384375-A920BF6A-629C-4489-B341-4636CC30B3C8

P356

1078-0432.CCR-08-3071

P1433

Clinical Cancer Research

P1476

A phase I trial of enzastaurin in patients with recurrent gliomas.

@en

P2093

Donald Thornton

http://www.w3.org/2001/XMLSchema#string

Howard A Fine

http://www.w3.org/2001/XMLSchema#string

Jennifer Walling

http://www.w3.org/2001/XMLSchema#string

Kraig Moore

http://www.w3.org/2001/XMLSchema#string

Luna Musib

http://www.w3.org/2001/XMLSchema#string

Lyndon Kim

http://www.w3.org/2001/XMLSchema#string

Paul Duic

http://www.w3.org/2001/XMLSchema#string

Paul S Albert

http://www.w3.org/2001/XMLSchema#string

Svetlana Kotliarova

http://www.w3.org/2001/XMLSchema#string

Teri N Kreisl

http://www.w3.org/2001/XMLSchema#string

P304

3617-3623

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-08-3071

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2009-05-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19417015

http://www.w3.org/2001/XMLSchema#string

P921

phase I clinical trial